Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Alto crecimiento de los beneficios
Los ingresos netos de la empresa lideran el sector. Sus ingresos anuales más recientes ascienden a 22.13B USD.
Alto dividendo
La empresa es una gran pagadora de dividendos. Su ratio de pago de dividendos más reciente es del 78.64%.
Dividendo estable
La empresa ha pagado dividendos de forma regular durante los últimos 5 años. Su ratio de pago de dividendos más reciente es del 78.64%.
Infravalorada
El PE más reciente de la empresa es 12.12, en un rango percentil bajo de 3 años.
Compra institucional
Las tenencias institucionales más recientes son 48.53M acciones, lo que supone un aumento del 0.28% con respecto al trimestre anterior.
En posesión de Richard Pzena
El inversor estrella Richard Pzena posee 31.22M acciones de este valor.